Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Sorafenib modulates the radio sensitivity of hepatocellular carcinoma cells in vitro in a schedule-dependent manner

Figure 1

Effect of sorafenib treatment on cell viability of irradiated SMMC-7721 (A) and BEL-7402 cells (B) . Cells were treated with radiation, sorafenib 30 min prior to irradiation (pre-IR sorafenib), or 24 h post irradiation (post-IR sorafenib), and MTT assays were performed to measure the viability of irradiated, treated cells. Cell viability was significantly lower in the post-irradiation sorafenib group versus the irradiation or pre-irradiation sorafenib group. Mean values were compared by using ANOVA. Mean ± SD (n = 3). *P < 0.05 vs. Radiation group.

Back to article page